Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
-
Global Crossing Airlines Sets Third Quarter 2024 Conference Call for November 7, 2024 at 8:30 a.m. ET
-
Territorial Reaffirms Board of Directors Recommendation that Territorial Shareholders Vote “FOR” Hope Bancorp Merger
-
ZenaTech Enters the Drone Sensor and Components Market Establishing a New Taiwan Subsidiary to Win More US Defense Contracts for Its AI Drones
-
Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution
-
Streamline Health® Adds Quality Module to Third eValuator™ Client
-
Cornerstone Financing announces $285 million financing from Aquiline and Nomura
-
23andMe Appoints Three New Independent Directors to Board
-
Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
-
Ollie’s Bargain Outlet Acquires Additional Former Big Lots Stores
-
Magna Debuts Scalable, Eco-Friendly ICE to Hybrid Transmission for European OEM
-
Hubbell Reports Third Quarter 2024 Results
-
CareMed Has Been Selected as a National Specialty Pharmacy Partner for Lecanemab-irmb (Leqembi®)
-
Polar Power Announces Preliminary 2024 Third Quarter Financial Results: Expected Net Sales of $4.7 - $5.2 Million and Gross Margin of 26%-32%
-
Fujifilm Launches New ECHELON Synergy 1.5T MRI System Software with AI Powered Workflow Enhancements
-
Ardena Expands Bioanalytical Services in Europe
-
Updated version of the company's articles of association
-
Verde's assays of over 1,500m of drilling find rare earths up to 12,487 ppm TREO and 3,357 ppm MREO
-
Bitget Wallet Launches Babylon Staking Program with Billion-Point Airdrop
-
H&E Rentals Reports Third Quarter 2024 Results
-
Vara Raises $8.9M in Funding While Expanding AI-Enabled Early Breast Cancer Detection to India
-
CECO Environmental to Acquire Profire Energy for $125 Million
-
Invivyd Reports Preliminary Third Quarter 2024 Results, Withdraws Prior Financial Guidance, and Targets Near-Term Profitability
-
Invivyd Phase 3 Long-Term Exploratory Clinical Efficacy Data Shows PEMGARDA™ (pemivibart) Provided Substantial Protection from Symptomatic COVID-19 Versus Placebo Over Six Months of Follow-Up, With
-
Evergold Options the Rockland Gold Property to Wolfden, and Wolfden Prepares to Drill
-
BioXcel Therapeutics to Present at ThinkEquity Conference
-
SeekOut Announces CHRO Council Workshop Series to Empower Talent Leaders
-
Skye Bioscience Names Independent Director Paul Grayson as Chairman of the Board
-
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions
-
2ONE Labs Receives PMTA 'Acceptance' for 2ONE® Nicotine Pouch brand from FDA Center for Tobacco Products
-
Captivision Announces Venture at Dream Hollywood Hotel
-
Beneficient to Present at the LD Micro Main Event XVII on October 30 in Los Angeles
-
Quris-AI Acquires Nortis
-
Sono-Tek Announces Participation at The Spartan Capital Investor Conference
-
CodeRoad Completes Carve-Out from Mojix to Become a Leading Independent Provider of Software Development & Technology Services
-
Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
-
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
-
Will 2025 See Lower Salary Increases? Salary.com Releases Latest National Salary Budget Survey
-
Bitterroot Bio Completes Enrollment in Phase 1 First-in-Human Study of BRB-002 in Healthy Volunteers
-
Ana Perez Joins PlanSource as Chief Marketing Officer
-
Toobit Unveils Redesigned Homepage, Elevating the User Experience for Global Crypto Traders
-
Atha Energy Announces Appointment of New Board Member and Chief Financial Officer
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Iris Energy Limited (NASDAQ:IREN) Investors to Contact the Firm
-
Creative Realities Inc. Shines as a Top Workplace, Empowering Employees in Greater Louisville
-
Breckenridge Distillery and Flaviar Partner to Release Dad’s Stash Whiskey in Support of No-Shave November, Raising Funds for Fight Colorectal Cancer (Fight CRC)
-
Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024
-
2ONE Labs Receives PMTA 'Acceptance' for 2ONE® Nicotine Pouch brand from FDA Center for Tobacco Products
-
Amplify ETFs Launches Targeted 12% Annual Option Premium Fixed Income ETF: Amplify Bloomberg U.S. Treasury Target High Income ETF (CBOE: TLTP)
-
Bitfarms Nominates Andrew J. Chang for Election to the Board of Directors
-
Perspective Therapeutics to Participate in Upcoming Investor Conferences in November


